Clinical Trials Directory

Trials / Completed

CompletedNCT04274647

Skin Sensitization Test (Modified Draize-95 Test)

Skin Sensitization Test (Modified Draize-95) to Support a Low Dermatitis Potential Claim

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
208 (actual)
Sponsor
YTY Industry (Manjung) Sdn Bhd · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Skin Sensitization Test (Modified Draize-95) to Support a Low Dermatitis Potential Claim for a Blue Non Sterile Powder Free Nitrile Examination Gloves. To evaluate whether residual chemical additives at a level that may induce type IV allergy in the unsensitized general user population are present in a finished rubber containing medical device.

Detailed description

1. To evaluate whether residual chemical additives at a level that may induce Type IV allergy in the unsensitized general user population are present in a finished rubber containing medical device. 2. To meet requirements for claim: This product demonstrated reduced potential for sensitizing users to chemical additives as described in Guidance for Industry and FDA Staff - Medical Glove Guidance Manual9. Supporting Test Data: A negative skin sensitization test (Modified Draize-95 Test) on a minimum of 200 non-sensitized human subjects.

Conditions

Interventions

TypeNameDescription
DEVICENON-STERILE, POWDER FREE NITRILE EXAMINATION GLOVES, LOW DERMATITIS POTENTIAL, TESTED FOR USE WITH CHEMOTHERAPY DRUGS - BLUEApproximately 2cm x 2cm square positioned to ensure that the inside portion of the test material maintained skin contact.

Timeline

Start date
2019-09-10
Primary completion
2020-02-04
Completion
2020-02-12
First posted
2020-02-18
Last updated
2020-02-18

Locations

1 site across 1 country: Malaysia

Source: ClinicalTrials.gov record NCT04274647. Inclusion in this directory is not an endorsement.